Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1
Year: 2017
Type: article
Abstract: The efficacy of β-lactam antibiotics is threatened by the emergence and global spread of metallo-β-lactamase (MBL) mediated resistance, specifically New Delhi metallo-β-lactamase-1 (NDM-1). By utilization of fragment-based drug discovery (FBDD), a new class of inhibitors for NDM-1 and two related β-lactamases, IMP-1 and VIM-2, was identified. On the basis of 2,6-dipicolinic acid (DPA), several libraries were synthesized for structure–activity relationship (SAR) analysis. Inhibitor 36 (IC 50 = 80 nM) was identified to be highly selective for MBLs when compared to other Zn(II) metalloenzymes. While DPA displayed a propensity to chelate metal ions from NDM-1, 36 formed a stable NDM-1:Zn(II):inhibitor ternary complex, as demonstrated by 1 H NMR, electron paramagnetic resonance (EPR) spectroscopy, equilibrium dialysis, intrinsic tryptophan fluorescence emission, and UV–vis spectroscopy. When coadministered with 36 (at concentrations nontoxic to mammalian cells), the minimum inhibitory concentrations (MICs) of imipenem against clinical isolates of Eschericia coli and Klebsiella pneumoniae harboring NDM-1 were reduced to susceptible levels.
Source: Journal of Medicinal Chemistry
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G3055346017, Medical Scientist Training Program, Challenges in beta-Lactamase Mediated Resistance, G4070144744, Developing Metallo-Beta-Lactamase Inhibitors, G5879789260, G6421724886, A Mechanism Based Approach to Metallo beta-lactamase Inhibition, Understanding B-Lactam Resistance in Acinetobacter baumannii
OpenAlex ID: W2746700384
